FDA Drug Recalls

Recalls / Class II

Class IID-1422-2014

Product

BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas 77478, NDC 75901-7210-53.

Affected lot / code info
Lot #: 6156-0, Exp 03/07/14

Why it was recalled

Presence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.

Recalling firm

Firm
Healix Infusion Therapy, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1075 W Park One Dr, Sugar Land, Texas 77478-2576

Distribution

Quantity
10 bags
Distribution pattern
Texas

Timeline

Recall initiated
2014-02-13
FDA classified
2014-07-07
Posted by FDA
2014-07-16
Terminated
2016-02-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1422-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls